8-103213038-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024812.3(BAALC):āc.280A>Gā(p.Ser94Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,614,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024812.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BAALC | NM_024812.3 | c.280A>G | p.Ser94Gly | missense_variant | 2/3 | ENST00000309982.10 | |
BAALC | NM_001364874.1 | c.385A>G | p.Ser129Gly | missense_variant | 3/4 | ||
BAALC | NM_001024372.2 | c.161-14951A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BAALC | ENST00000309982.10 | c.280A>G | p.Ser94Gly | missense_variant | 2/3 | 1 | NM_024812.3 | P1 | |
BAALC-AS1 | ENST00000499522.6 | n.985+21242T>C | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152228Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251192Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135740
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461824Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 727210
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.280A>G (p.S94G) alteration is located in exon 2 (coding exon 2) of the BAALC gene. This alteration results from a A to G substitution at nucleotide position 280, causing the serine (S) at amino acid position 94 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at